|
DDX50 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.61730000023542E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.40080000043952E-07 |
| Normal-vs-Stage2 |
2.93900000003511E-06 |
| Normal-vs-Stage3 |
1.796800E-04 |
| Normal-vs-Stage4 |
1.271160E-01 |
| Stage1-vs-Stage2 |
6.230000E-01 |
| Stage1-vs-Stage3 |
5.192200E-01 |
| Stage1-vs-Stage4 |
1.495220E-01 |
| Stage2-vs-Stage3 |
2.678000E-01 |
| Stage2-vs-Stage4 |
7.801700E-02 |
| Stage3-vs-Stage4 |
2.928000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.69990000035092E-07 |
| Normal-vs-AfricanAmerican |
2.406700E-04 |
| Normal-vs-Asian |
1.352170E-01 |
| Caucasian-vs-AfricanAmerican |
3.639200E-01 |
| Caucasian-vs-Asian |
3.751400E-01 |
| AfricanAmerican-vs-Asian |
5.934200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.38070016425718E-10 |
| Normal-vs-Female |
3.567600E-02 |
| Male-vs-Female |
3.82649999997042E-06 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.34349999999051E-05 |
| Normal-vs-Extreme_Weight |
8.20190000361265E-08 |
| Normal-vs-Obese |
2.583400E-04 |
| Normal-vs-Extreme_Obese |
2.47700000000073E-05 |
| Normal_Weight-vs-Extreme_Weight |
5.453200E-01 |
| Normal_Weight-vs-Obese |
2.921400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.210400E-01 |
| Extreme_Weight-vs-Obese |
4.416500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.234200E-01 |
| Obese-vs-Extreme_Obese |
7.086000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.649000E-01 |
| Normal-vs-Age(41-60Yrs) |
8.01759999999874E-05 |
| Normal-vs-Age(61-80Yrs) |
5.75120000512186E-08 |
| Normal-vs-Age(81-100Yrs) |
2.80900000004802E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.014000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.318000E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.838800E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.797600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.695600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.238000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.69269999922884E-08 |
| Normal-VS-Type2 PRCC |
1.30820000387999E-08 |
| Normal-VS-KIRP CIMP |
8.507600E-01 |
| Normal-VS-Unclassified PRCC |
1.561200E-03 |
| Type1 PRCC-VS-Type2 PRCC |
3.992400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.639300E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
2.948800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.806390E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.271040E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.214200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.10100004061076E-09 |
| Normal-vs-N1 |
8.232000E-02 |
| Normal-vs-N2 |
1.240190E-01 |
| N0-vs-N1 |
1.223770E-03 |
| N0-vs-N2 |
1.966830E-01 |
| N1-vs-N2 |
7.020800E-01 |
|
|
